SCA 40: studies of the relaxant effects on cryopreserved human airway and vascular smooth muscle
Open Access
- 1 March 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 120 (7), 1241-1248
- https://doi.org/10.1038/sj.bjp.0701037
Abstract
1. 6-Bromo-8-methylaminoimidazol[1,2-a]pyrazine-2carbonitrile (SCA 40) has been claimed to induce relaxation in guinea-pig trachea by opening high conductance, calcium-activated potassium (BKCa) channels. The mechanism of action of SCA 40 has now been further investigated in ring preparations from cryopreserved human airway and vascular smooth muscle preparations in vitro. 2. Human bronchi with spontaneous tone relaxed in response to SCA 40 in a biphasic way. A high affinity component (pD2 8.61 +/- 0.21; mean +/- s.e.mean) accounted for 30% of the response and a low affinity component (pD2 6.53 +/- 0.14) for the remaining 70%. In contrast, in bronchi contracted with carbachol, 1 microM, the concentration-response curve to SCA 40 was monophasic and yielded a pD2 of 6.31 +/- 0.29. 3. SCA 40 relaxed pulmonary and mesenteric arteries and peripheral veins which had been precontracted by 10 nM U46619 nearly completely and in a monophasic way; the pD2 values were 6.37 +/- 0.08, 6.17 +/- 0.15 and 5.45 +/- 0.25, respectively. 4. Lemakalim, an opener of ATP-dependent potassium (KATP) channels, also relaxed human bronchi under spontaneous tone and the vascular tissues. NS 1619, a recognised opener of BKca channels, was inactive up to 10 microM on bronchial and vascular tissues. 5. The SCA 40-induced relaxation of human bronchi was reduced concentration-dependently in the presence of high potassium chloride (20 and 80 mM). However, in the presence of 80 mM KCl and nifedipine, 30 nM, SCA 40 fully relaxed the remaining contractile response with pD2 values of 8.08 +/- 0.13 and 5.27 +/- 0.13 for the high and low affinity component, respectively. 6. Relaxation responses to SCA 40 in human bronchi were resistant to blockade by glibenclamide at concentrations up to 10 microM (which blocked the relaxant response to lemakalim), quinine (30 microM), apamin (100 nM), tetraethylammonium (0.1-1 mM) and charybdotoxin (10-100 nM), thus excluding the involvement of a variety of K+ channels including KATP and KCa channels. 7. In bronchi contracted with carbachol, 1 microM, the nature of the interaction between SCA 40 and the beta 2-adrenoceptor agonist, salbutamol, was synergistic. 8. These experiments establish that SCA 40 is a potent relaxant of human bronchial smooth muscle manifesting spontaneous tone. A low affinity relaxant component has its counterpart in the relaxation seen in both human arterial and venous smooth muscle. The consensus of the evidence suggests that K+ channel opening is not the basis of the relaxant response to SCA 40. Furthermore, BKCa channels appear to be of minor importance in the regulation of human airway smooth muscle tone. Our data suggest that inhibition of an adenosine 3':5'-cyclic monophosphate phosphodiesterase may contribute, at least to the low affinity relaxant component of SCA 40. However, the exact mechanism mediating the SCA 40-induced relaxation of human airways remains to be defined.Keywords
This publication has 24 references indexed in Scilit:
- Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalimBritish Journal of Pharmacology, 1996
- Functional, biochemical and morphological studies on human bronchi after cryopreservationBritish Journal of Pharmacology, 1995
- A comparison of the effects of SCA40, NS 004 and NS 1619 on large conductance Ca2+-activated K+ channels in bovine tracheal smooth muscle cells in cultureBritish Journal of Pharmacology, 1995
- Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40British Journal of Pharmacology, 1995
- Cardiovascular effects of SCA40, a novel potassium channel opener, in ratsBritish Journal of Pharmacology, 1993
- Evaluation of the relaxant effects of SCA40, a novel charybdotoxin‐sensitive potassium channel opener, in guinea‐pig isolated trachealisBritish Journal of Pharmacology, 1993
- Bronchodilating effects of the novel potassium channel opener HOE 234 in human airways in vitro.British Journal of Clinical Pharmacology, 1993
- Role of Potassium Channels in Bronchodilator Responses in Human AirwaysAmerican Review of Respiratory Disease, 1992
- The Action of a Potassium Channel Activator, BRL 38227 (Lemakalim), on Human Airway Smooth MuscleAmerican Review of Respiratory Disease, 1990
- The spontaneous electrical and mechanical activity of human bronchial smooth muscle: its modulation by drugsBritish Journal of Pharmacology, 1989